Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

George Mark

Clinical Cardiac Electrophysiology Haddon Heights, NJ Medical Doctor

NPI 1265516488 CMS profile 148423

210 W Atlantic Ave, Haddon Heights, NJ 08035

Open in the dashboard

General payments

$311,841

1,097 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$622,666 paid to institutions, not to them · program years 2019–2025

Through program year 2024, George Mark of Haddon Heights, NJ is reported in the CMS Open Payments database as having received $311,841 across 1,097 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $622,666 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $34,512 133
2023 General $53,368 183
2022 General $60,553 192
2021 General $30,897 186
2020 General $31,559 164
2019 General $100,952 239

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Mark
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to George Mark were reported at $0. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year George Mark Clinical Cardiac Electrophysiology median Middle half National median
2019 $100,952 $2,361 $585–$8,260 $163
2020 $31,559 $993 $247–$4,351 $114
2021 $30,897 $1,185 $326–$4,739 $132
2022 $60,553 $2,073 $554–$6,789 $149
2023 $53,368 $2,568 $759–$8,159 $160
2024 $34,512 $2,557 $703–$7,403 $164
2025 $0 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Boston Scientific Corporation $132,581 200 payments
  2. Abbott Laboratories $81,659 437 payments
  3. Impulse Dynamics (USA) Inc. $40,031 83 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29,307 72 payments
  5. E.R. Squibb & Sons, L.L.C. $11,702 31 payments
  6. Biotronik Inc. $3,861 51 payments
  7. Biosense Webster, Inc. $3,747 43 payments
  8. Pfizer Inc. $3,174 24 payments
  9. Medical Device Business Services, Inc. $2,275 2 payments
  10. Atricure, Inc. $805 16 payments
  11. Other $2,699 138 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $104,705 59 payments
  2. Consulting Fee $98,475 60 payments
  3. Travel and Lodging $42,818 99 payments
  4. Food and Beverage $29,099 844 payments
  5. Honoraria $25,300 14 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $7,000 5 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $3,863 5 payments
  8. Education $582 11 payments
Products named General payments · program years 2019–2024
  1. WATCHMAN $45,733 51 payments
  2. AMPLATZER AMULET $43,373 58 payments
  3. LifeVest $29,307 72 payments
  4. Optimizer Cardiovascular $20,462 29 payments
  5. WATCHMAN Access System $18,508 37 payments
  6. OPTIMIZER Cardiovascular Device $13,406 28 payments
  7. OPTIMIZER Cardiovascular Device $13,406 28 payments
  8. GENERAL THERAPIES $11,792 12 payments
  9. Ensite Cardiac Mapping System $11,723 8 payments
  10. WATCHMAN FLX $11,300 9 payments
  11. Other $106,282 835 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

1,257

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$468,661

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

40.7%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 307 $353,773
Xarelto Rivaroxaban Brand 51 $71,539
Entresto Sacubitril/Valsartan Brand 18 $14,911
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 21 $8,194
Brilinta Ticagrelor Brand 12 $5,498
Flecainide Acetate Generic 91 $3,469
Metoprolol Succinate Generic 145 $2,339
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 34 $1,738
Amiodarone Hcl Generic 29 $1,125
Metoprolol Tartrate Generic 84 $893

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$453,977

Medicare's payments for the services billed

Medicare patients

1,778

Average age 76

Services billed

6,831

858 women, 920 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 63%
Ischemic heart disease 55%
Arthritis 51%
Heart failure 48%
Diabetes 44%
Chronic kidney disease 43%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
$35 51 —
LEQVIO
$29 — —
ELIQUIS
$28 307 —
Arcalyst
$28 — —
AMVUTTRA
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

1,097 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record